1. Home
  2. AWRE vs CELU Comparison

AWRE vs CELU Comparison

Compare AWRE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aware Inc.

AWRE

Aware Inc.

N/A

Current Price

$2.10

Market Cap

44.7M

Sector

Technology

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.39

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWRE
CELU
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7M
50.7M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AWRE
CELU
Price
$2.10
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
34.6K
62.5K
Earning Date
10-29-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,428,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
2.72
N/A
52 Week Low
$1.37
$1.00
52 Week High
$2.95
$4.35

Technical Indicators

Market Signals
Indicator
AWRE
CELU
Relative Strength Index (RSI) 42.66 27.95
Support Level $1.97 $1.62
Resistance Level $2.22 $2.01
Average True Range (ATR) 0.12 0.13
MACD 0.00 -0.04
Stochastic Oscillator 32.52 1.72

Price Performance

Historical Comparison
AWRE
CELU

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: